| Disease | thrombocytosis |
| Phenotype | C0027022|chronic myeloproliferative disease |
| Sentences | 1 |
| PubMedID- 25389097 | Czech working group for ph-negative myeloproliferative diseases (czemp) recommends anagrelid (thromboreductin(r)) for the treatment of ph-negative chronic myeloproliferative disease (mpo) with thrombocythemia accompanying. |
Page: 1